Utilizing aromatase inhibitors compared with tamoxifen reduce recurrence in estrogen receptor-positive breast cancer in patients who were menopausal and received ovarian suppression. A meta-analysis of 4 trials investigated using aramatase inhibitors ...
from Google Alert - health https://ift.tt/31EgzLr
via IFTTT
0 comments:
Post a Comment